URGN UroGen Pharma Ltd. - Ordinary Shares

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$29.25
Price · May 20, 2026
Fundamentals as of May 6, 2026

URGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$29.25
Market Cap
$1.13B
P/E (TTM)
EPS (TTM)
Revenue (TTM)
$110M
Div Yield
ROE
154.4%
Debt/Equity
-1.2
52W Range
$3 – $32

URGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $110M
10-point trend, +526.3%
2016-12-31 2025-12-31
EPS
Free Cash Flow $-163M
5-point trend, -329.4%
2018-12-31 2025-12-31
Margins -139.8%
5-point trend, +248.2%
2018-12-31 2025-12-31

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
URGN
Peer Median
P/S (TTM)
5-point trend, -98.3%
10.3
4.7
P/B
5-point trend, -238.5%
-10.7
2.0
EV / EBITDA
-8.8
Price / FCF
5-point trend, +62.2%
-7.0

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
URGN
Peer Median
Gross Margin
5-point trend, +248.2%
88.7%
63.0%
Operating Margin
5-point trend, +98.3%
-113.7%
Net Profit Margin
5-point trend, +97.9%
-139.8%
-319.4%
ROA
5-point trend, +25.3%
-63.1%
-72.0%
ROE
5-point trend, +297.6%
154.4%
-92.2%
ROIC
4-point trend, -769.9%
-746.5%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
URGN
Peer Median
Debt / Equity
-1.2
0.0
Current Ratio
5-point trend, -47.2%
4.0
4.3
Quick Ratio
5-point trend, -44.7%
4.2

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
URGN
Peer Median
Revenue YoY
5-point trend, +128.5%
21.4%
Revenue CAGR 3Y
5-point trend, +128.5%
19.5%
Revenue CAGR 5Y
5-point trend, +128.5%
56.2%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
URGN
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
URGN
Peer Median

URGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 14 analysts
  • Strong Buy 5 35.7%
  • Buy 7 50.0%
  • Hold 2 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

9 analysts · 2026-05-19
Median target $40.00 +36.8%
Mean target $36.44 +24.6%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.06%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-0.47 $-0.49 0.02%
Dec. 31, 2025 $-0.54 $-0.51 -0.03%
Sept. 30, 2025 $-0.69 $-0.71 0.02%
June 30, 2025 $-1.05 $-0.85 -0.20%
March 31, 2025 $-0.92 $-0.82 -0.10%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
URGN $1.13B 21.4% -139.8% 154.4% 88.7%
KMDA
CGEN
ENLV
ENTX $90M 7.8 -76.8% -27235.7% -75.4% 0.00%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 15
Annual Income Statement data for URGN
Metric Trend 202520242023202220212020201920182017
Revenue 9-point trend, +1245.8% $110M $90M $83M $64M $48M $12M $18.0K $1M $8M
Cost of Revenue 8-point trend, +1974.5% $12M $9M $9M $8M $5M $1M · $2M $600.0K
Gross Profit 9-point trend, +1187.9% $97M $82M $73M $57M $43M $11M $18.0K $-675.0K $8M
R&D Expense 9-point trend, +258.9% $67M $57M $46M $53M $48M $47M $49M $37M $19M
SG&A Expense 9-point trend, +1660.3% $155M $121M $93M $83M $88M $90M $60M $40M $9M
Operating Expenses 3-point trend, +298.1% · · · · · · $109M $77M $28M
Operating Income 9-point trend, -525.9% $-125M $-97M $-66M $-79M $-92M $-127M $-109M $-77M $-20M
Interest Income 7-point trend, +29.2% $6M $9M $3M $938.0K $365.0K $2M $5M · ·
Other Non-op 8-point trend, -5683.3% $-670.0K $-229.0K $838.0K $72.0K $-153.0K · $-284.0K $-124.0K $12.0K
Pretax Income 9-point trend, -667.8% $-153M $-124M $-98M $-108M $-109M $-125M $-105M $-76M $-20M
Income Tax 8-point trend, +310.5% $78.0K $3M $4M $2M $1M $3M · $125.0K $19.0K
Net Income 9-point trend, -667.5% $-153M $-127M $-102M $-110M $-111M $-128M $-105M $-76M $-20M
EPS (Basic) 5-point trend, +35.7% $-3.19 $-2.96 $-3.55 $-4.81 $-4.96 · · · ·
Shares (Basic) 5-point trend, +115.3% 48,116,098 42,876,737 28,834,303 22,806,812 22,347,481 · · · ·
EBITDA 5-point trend, -62.2% $-125M · · · $-91M $-126M $-109M $-77M ·
Balance Sheet 24
Annual Balance Sheet data for URGN
Metric Trend 202520242023202220212020201920182017
Cash & Equivalents 9-point trend, +199.3% $111M $172M $95M $55M $44M $53M $50M $101M $37M
Short-term Investments 4-point trend, +37.0% $49M $111M $56M · · · · · $36M
Receivables 6-point trend, +369.4% $33M $20M $15M $13M $12M $7M · · ·
Inventory 7-point trend, +5110.1% $16M $9M $6M $4M $5M $2M · · $316.0K
Prepaid Expense 9-point trend, +1431.5% $15M $9M $10M $11M $7M $3M $1M $672.0K $958.0K
Current Assets 9-point trend, +149.8% $186M $276M $169M $129M $114M $116M $149M $102M $74M
PP&E (Net) 9-point trend, -20.9% $637.0K $655.0K $689.0K $1M $2M $2M $977.0K $948.0K $805.0K
PP&E (Gross) 9-point trend, +278.0% $5M $5M $5M $4M $4M $3M $2M $2M $1M
Accum. Depreciation 9-point trend, +695.0% $5M $4M $4M $3M $2M $1M $998.0K $747.0K $577.0K
Other Non-current Assets 9-point trend, +2015.2% $5M $589.0K $2M $3M $1M $66.0K $264.0K $317.0K $244.0K
Total Assets 9-point trend, +165.3% $200M $286M $178M $136M $120M $122M $202M $104M $76M
Accounts Payable 9-point trend, +327.5% $12M $11M $7M $6M $6M $3M $5M $4M $3M
Current Liabilities 9-point trend, +559.8% $46M $46M $31M $24M $22M $21M $19M $13M $7M
Capital Leases 7-point trend, +1.6% $3M $58.0K $0 $2M $398.0K $1M $3M · ·
Total Liabilities 9-point trend, +4248.7% $306M $295M $244M $225M $111M $26M $22M $13M $7M
Long-term Debt $125M · · · · · · · ·
Total Debt $122M · · · · · · · ·
Common Stock 9-point trend, +259.5% $133.0K $115.0K $89.0K $63.0K $61.0K $60.0K $57.0K $44.0K $37.0K
Paid-in Capital 2-point trend, +84.0% · · · · · · · $213M $116M
Retained Earnings 9-point trend, -1932.7% $-960M $-806M $-679M $-577M $-467M $-357M $-228M $-123M $-47M
AOCI 7-point trend, -93.1% $19.0K $56.0K $12.0K $-107.0K $-25.0K $271.0K $276.0K · ·
Stockholders' Equity 9-point trend, -253.9% $-105M $-9M $-65M $-89M $8M $96M $180M $90M $69M
Liabilities + Equity 9-point trend, +165.3% $200M $286M $178M $136M $120M $122M $202M $104M $76M
Shares Outstanding 9-point trend, +251.6% 48,350,272 42,231,746 32,490,119 23,129,953 22,462,995 22,167,791 21,026,184 16,214,883 13,751,390
Cash Flow 14
Annual Cash Flow data for URGN
Metric Trend 202520242023202220212020201920182017
D&A 9-point trend, +53.5% $307.0K $329.0K $802.0K $924.0K $831.0K $416.0K $300.0K $400.0K $200.0K
Stock-based Comp 9-point trend, +89.8% $12M $13M $9M $11M $23M $28M $30M $31M $6M
Other Non-cash 5-point trend, -391.4% $-21M · · · $2M $-6M $4M $7M ·
Operating Cash Flow 9-point trend, -1597.8% $-162M $-97M $-76M $-88M $-85M $-106M $-71M $-37M $-10M
CapEx 9-point trend, +6.6% $289.0K $295.0K $194.0K $254.0K $752.0K $1M $325.0K $560.0K $271.0K
Investing Cash Flow 9-point trend, +269.7% $62M $-21M $-953.0K $1M $4M $93M $-146M $35M $-36M
Debt Issued 5-point trend, +0.00 $0 $24M $0 $96M $0 · · · ·
Net Debt Issued $0 · · · · · · · ·
Stock Issued 9-point trend, -34.6% $40M $151M $67M $0 $0 $16M $162M $64M $61M
Net Stock Activity 5-point trend, -38.0% $40M · · · $0 $16M $162M $64M ·
Financing Cash Flow 9-point trend, -35.2% $40M $195M $117M $97M $72M $17M $165M $66M $62M
Net Change in Cash 9-point trend, -487.3% $-61M $77M $40M $11M $-9M $4M $-51M $64M $16M
Taxes Paid 2-point trend, +66.7% $3M $2M · · · · · · ·
Free Cash Flow 5-point trend, -329.4% $-163M · · · $-86M $-107M $-71M $-38M ·
Profitability 8
Annual Profitability data for URGN
Metric Trend 202520242023202220212020201920182017
Gross Margin 5-point trend, +248.2% 88.7% · · · 89.3% 91.5% 100.0% -59.8% ·
Operating Margin 5-point trend, +98.3% -113.7% · · · -192.1% -1074.2% -608211.1% -6842.2% ·
Net Margin 5-point trend, +97.9% -139.8% · · · -230.7% -1088.9% -584144.4% -6707.2% ·
Pretax Margin 5-point trend, +97.9% -139.7% · · · -227.7% -1060.3% -584144.4% -6696.1% ·
EBITDA Margin 5-point trend, +98.3% -113.5% · · · -190.4% -1070.8% -606544.4% -6806.7% ·
ROA 5-point trend, +25.3% -63.1% · · · -91.7% -79.2% -68.7% -84.5% ·
ROE 5-point trend, +297.6% 154.4% · · · -554.8% -118.5% -53.8% -78.1% ·
ROIC 4-point trend, -769.9% -746.5% · · · -1111.6% -135.1% · -85.8% ·
Liquidity & Solvency 4
Annual Liquidity & Solvency data for URGN
Metric Trend 202520242023202220212020201920182017
Current Ratio 5-point trend, -47.2% 4.0 · · · 5.1 5.4 7.6 7.6 ·
Quick Ratio 5-point trend, -44.7% 4.2 · · · 2.5 2.8 2.6 7.5 ·
Debt / Equity -1.2 · · · · · · · ·
LT Debt / Equity -1.2 · · · · · · · ·
Efficiency 3
Annual Efficiency data for URGN
Metric Trend 202520242023202220212020201920182017
Asset Turnover 5-point trend, +3484.1% 0.5 · · · 0.4 0.1 0.0 0.0 ·
Inventory Turnover 3-point trend, +9.5% 1.0 · · · 1.5 0.9 · · ·
Receivables Turnover 3-point trend, +22.8% 4.1 · · · 5.1 3.3 · · ·
Per Share 2
Annual Per Share data for URGN
Metric Trend 202520242023202220212020201920182017
Book Value / Share 5-point trend, -139.3% $-2.18 · · · $0.37 $4.35 $8.58 $5.56 ·
Cash / Share 5-point trend, -63.3% $2.29 · · · $1.97 $2.38 $2.36 $6.25 ·
Growth Rates 3
Annual Growth Rates data for URGN
Metric Trend 202520242023202220212020201920182017
Revenue YoY 5-point trend, -93.0% 21.4% 9.3% 28.5% 34.0% 307.2% · · · ·
Revenue CAGR 3Y 3-point trend, -78.7% 19.5% 23.5% 91.4% · · · · · ·
Revenue CAGR 5Y 56.2% · · · · · · · ·
Valuation (TTM) 12
Annual Valuation (TTM) data for URGN
Metric Trend 202520242023202220212020201920182017
Revenue TTM 8-point trend, +9633.0% $110M $90M $83M $64M $48M $12M $18.0K $1M ·
Net Income TTM 8-point trend, -102.9% $-153M $-127M $-102M $-110M $-111M $-128M $-105M $-76M ·
Market Cap 5-point trend, +62.2% $1.13B · · · $214M $399M $702M $698M ·
Enterprise Value $1.09B · · · · · · · ·
P/S 5-point trend, -98.3% 10.3 · · · 4.4 33.9 38980.2 619.0 ·
P/B 5-point trend, -238.5% -10.7 · · · 25.4 4.1 3.9 7.7 ·
P / Tangible Book 2-point trend, +512.5% · · · · 25.4 4.1 · · ·
P / Cash Flow 5-point trend, +62.7% -7.0 · · · -2.5 -3.8 -9.9 -18.7 ·
P / FCF 5-point trend, +62.2% -7.0 · · · -2.5 -3.7 -9.8 -18.4 ·
EV / EBITDA -8.8 · · · · · · · ·
EV / FCF -6.7 · · · · · · · ·
EV / Revenue 10.0 · · · · · · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $110M$90M$83M$64M$48M
Gross Margin % 88.7%89.3%
Operating Margin % -113.7%-192.1%
Net Income $-153M$-127M$-102M$-110M$-111M
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity -1.2
Current Ratio 4.05.1
Quick Ratio 4.22.5
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-163M$-86M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.